Voyager Therapeutics (NASDAQ:VYGR) Receives Outperform Rating from Oppenheimer

Oppenheimer reissued their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Oppenheimer currently has a $18.00 price objective on the stock. Several other analysts also recently commented on the stock. StockNews.com downgraded shares of Voyager Therapeutics from a buy rating to […]

Related Keywords

China , , Nasdaq , Citigroup , Tower Research Capital , China Universal Asset Management Co , Ameritas Investment Partners Inc , Voyager Therapeutics Inc , Voyager Therapeutics , Free Report , Moderate Buy , Therapeutics Trading Down , Get Free Report , Capital Management , Investment Partners , Universal Asset Management , Research Capital , Voyager Therapeutics Daily ,